Comstock Holding Companies, Inc.
NASDAQ:CHCIReal Estate - Diversified
+$0.31 today
- Market cap
- $152.74M
- Beta
- -0.43
- P/E (TTM)
- 8.8
- EPS (TTM)
- $1.71
Volume 0.05M
Average 0.02M
CHCI Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Comstock Holding Companies, Inc.NASDAQ: CHCI
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How CHCI compares with its peers on the latest reported figures
- CHCI's LTM Mar 2026 research & development of $0 is the 2nd highest of the 11 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for CHCI, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $11.11M | -48.3% | +20.6% | 1027.5% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Jan 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding CHCI) | $0 | -48.3% | +20.6% | 0.0% | |
Competitors are the stored peer set for CHCI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 31.09M | 39.31M | 44.72M | 51.29M | 62.86M |
| Cost of Revenue | 24.65M | 29.37M | 33.04M | 38.63M | 48.08M |
| Gross Profit | 6.44M | 9.94M | 11.68M | 12.66M | 14.78M |
| Gross Margin | 20.7% | 25.3% | 26.1% | 24.7% | 23.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.29M | 1.78M | 2.31M | 2.08M | 2.55M |
| Operating Expenses | 1.38M | 1.99M | 2.52M | 2.38M | 2.85M |
| Depreciation & Amortization | 94K | 206K | 212K | 302K | 306K |
| EBITDA | 5.16M | 8.28M | 8.36M | 11.03M | 13.18M |
| EBITDA Margin | 16.6% | 21.1% | 18.7% | 21.5% | 21.0% |
| Operating Income | 5.07M | 7.95M | 9.16M | 10.29M | 11.93M |
| Operating Margin | 16.3% | 20.2% | 20.5% | 20.1% | 19.0% |
| Interest Income | 0 | 0 | 96K | 672K | 807K |
| Interest Expense | 235K | 222K | 0 | 0 | 0 |
| Other Income / Expenses | (243K) | (99K) | (1.01M) | 438K | 947K |
| Income Before Tax | 4.82M | 7.85M | 8.15M | 10.73M | 12.88M |
| Pre-Tax Margin | 15.5% | 20.0% | 18.2% | 20.9% | 20.5% |
| Income Tax Expense | (11.22M) | 125K | 368K | (3.84M) | (4.17M) |
| Net Income | 13.61M | 7.35M | 7.78M | 14.56M | 17.05M |
| Net Margin | 43.8% | 18.7% | 17.4% | 28.4% | 27.1% |
| EPS (Basic) | 1.66 | 1.09 | 0.81 | 1.48 | 1.69 |
| EPS (Diluted) | 1.50 | 0.98 | 0.77 | 1.41 | 1.63 |
| Weighted Avg Shares | 8.21M | 8.97M | 9.63M | 9.85M | 10.07M |
| Weighted Avg Shares (Diluted) | 9.1M | 9.58M | 10.11M | 10.33M | 10.47M |
Comstock Holding Companies, Inc.
NASDAQ:CHCI
Intrinsic Alpha fair value
Locked
Current Price
$15.18
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.